Briefing Summary: US FDA Posts Advisory Committee Materials for Luxturna, a Gene Therapy Proposed by Spark Therapeutics to Treat a Rare Pediatric Vision Disease Report
Briefing Summary: US FDA Posts Advisory Committee Materials for Luxturna, a Gene Therapy Proposed by Spark Therapeutics to Treat a Rare Pediatric Vision Disease Report